Canada’s specialty commercialization, patient support, and distribution partner—helping therapies reach patients faster
Our guiding principle is simple: When your patients are well supported, so is your product.
Our active commitment to exceptional patient care is why we established an integrated healthcare service network that reaches across Canada. It’s how we ensure your patients experience reliable access to your product, as well as seamless, quality care throughout their treatment journey.
Webinar - Clinical trials in Canada: Regulatory framework
Considering Canada for your next clinical trial? A strong regulatory strategy begins with a clear understanding of the Canadian framework and the requirements that shape a Clinical Trial Application (CTA).
In this webinar, Adam Buffone, Director, Regulatory Affairs at Innomar, will provide a practical overview of the Canadian CTA pathway, from determining whether an application is required to preparing a submission and navigating Health Canada’s review process. Attendees will learn how Canada’s regulatory requirements can influence trial planning, submission strategy, and ongoing authorization.
The session will examine the regulatory framework established under Division 5 of the Food and Drug Regulations, including when a CTA is required and when one may not be needed. It will also introduce the role of Health Canada’s Health Products and Food Branch, key considerations for pre-CTA consultations, the structure and submission of a Canadian CTA, and what sponsors can expect during regulatory review.
Who we support
Careers with purpose
